Columbus A/S
| Company announcement no. 9/2021 March 24th, 2021 Major shareholder information pursuant to section 30 of the Danish Capital Markets Act |
Company announcement
Pursuant to Section 30 of the Danish Capital Markets Act, Columbus A/S hereby announces that it has today received notification that as of 23 March 2021 Protector Forsikring ASA, Org no. 985279721 no longer holds above 5% of the shares and voting rights of Columbus A/S.
The notification received from Protector Forsikring ASA is as follows:
"Subject: Major shareholder notification for Columbus
Message:
Hi
According to Danish Capital Market Act, we hereby notify you that we have crossed the thresholds of 5% from 5,03% to 4,96% percent of the issuing company’s share capital.
On the 23rd of March 2021, Protector Forsikring ASA ,orgnr 985279721, sold 88 286 shares of Columbus (ISIN: DK0010268366).
This gives us a total holding of 6 179 456 shares, 4,96%."
Ib Kunøe Hans Henrik Thrane
Chairman of the Board Interim CEO & Corporate CFO
For further information, please contact: Interim CEO & Corporate CFO, Hans Henrik Thrane, hht@columbusglobal.com, +45 70 20 50 00 |
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
The Magnum Ice Cream Company N.V.24.12.2025 11:52:30 CET | Press release
Director/PDMR Shareholding
Afarak Group SE24.12.2025 10:00:00 CET | Press release
AFARAK GROUP SE: DISTRIBUTION OF ASSETS FROM THE RESERVE FOR INVESTED UNRESTRICTED EQUITY
Sanofi Winthrop Industrie24.12.2025 07:15:00 CET | Press release
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
FLSmidth A/S24.12.2025 07:00:00 CET | Press release
FLSmidth: Transactions under share buy-back programme
Sanofi Winthrop Industrie24.12.2025 07:00:00 CET | Press release
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
